Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
No head to head comparisons between exenatide once weekly and liraglutide have been
performed. Therefore, the purpose of this study is to compare exenatide once weekly to
once-daily liraglutide with regard to HbA1c, body weight, subject-reported outcomes, and
other clinical benefits. The study includes a 26-week treatment period and a safety follow-up
visit 10 weeks after the final study drug dose.